Public filings / XENE on Yahoo Finance (opens in a new tab)
XENE: insider buying, 13F holders, analyst moves
Xenon Pharmaceuticals Inc - US
A summary of public filings about Xenon Pharmaceuticals Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold XENE
Combined reported value $515.9M.
Holders among our 100 managers: 4 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Avoro Capital Advisors | $348.7M | 3.13% | Unchanged |
| Deerfield Company | $97.5M | 1.02% | Unchanged |
| Tudor Investment | $32.9M | 0.14% | Added |
| Baker Bros. Advisors | $22.3M | 0.11% | Unchanged |
| Duquesne Family Office | $14.4M | 0.33% | Unchanged |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.